Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-03

Clinical Trial Update: Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and pharmacokinetics of armodafinil (Provigil) in shift work sleep disorder completed; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Provigil (Modafinil)

Snippet

Sponsor: Cephalon | Conditions: Chronic Shift Work Sleep Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-02-03